Five more die of COVID-19 related causes in Hidalgo County; 183 more positive cases

Breaking NewsCommunity News
909

Translate to Spanish or other 102 languages!

Image for illustration purposes only

Mega Doctor News

- Advertisement -

EDINBURG – Five more Hidalgo County residents died from COVID-19 related causes and 183 more people tested positive, officials with the Hidalgo County Health and Human Services Department reported Tuesday. Numbers were not compiled for Wednesday, which was Veterans Day.

“Five new deaths from this disease may seem small relative to the death toll from recent days, but they represent much more to the family and friends of those who perished,” Hidalgo County Richard F. Cortez said. “I offer my condolences to those families affected by these deaths and my sincere prayers that the death toll from this virus eventually ends.”

The deaths include:

- Advertisement -

Among the positive cases include:

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
UTRGV student shares story after contracting COVID-19, urges caution
Next article
Four people die of COVID-19 related causes in Hidalgo County; 199 more positive cases

More Articles

STHS Edinburg Solidifies Leadership in Advanced Care with Triple Surgical Reaccreditation

There’s no doubt that advancements in surgical technology are changing lives, shifting care away from traditional open procedures toward less invasive, more precise techniques that promote faster healing and improved outcomes.

STHS Heart Earns Level 3 Geriatric Emergency Department Accreditation

Health challenges can affect individuals at any stage of life, but the likelihood of complications rises significantly with age.

Texas Adds New Condition to Mandatory Newborn Screening Tests

The Texas Department of State Health Services added a new enzyme deficiency test on June 1, 2026, to its newborn screening panel, meaning that all Texas newborns are now tested for 60 rare, genetic conditions. Tests for hearing loss and critical congenital heart disease are additional point-of-service tests typically conducted by the birthing center. 

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.
- Advertisement -